Straumann Holding AG is a leading global medical technology company focused on dental implantology and digital dentistry solutions. The company develops, manufactures, and markets premium dental implants and restorative products, including titanium-zirconium alloy implants under the Straumann BLX and Roxolid brands; tissue regeneration materials such as Emdogain and botiss biomaterials; guided surgery and digital workflow systems like the Straumann CT Scanner and coDiagnostiX software; CAD/CAM prosthetics via the Straumann CARES ecosystem; and orthodontic aligners through the ClearCorrect brand; as well as regenerative tissue solutions and digital dentistry services. Straumann serves dental professionals, laboratories, and distribution partners worldwide, with primary operations spanning Europe, North America, Asia-Pacific, Latin America, and Africa; it was founded in 1954 and is headquartered in Basel, Switzerland. Subsidiaries include Curaden AG for instruments and Smartoux for orthodontics, with no parent company. Recent developments include the 2024 acquisition of Nuvola, enhancing intraoral scanning capabilities; a strategic partnership with Greencor to advance sustainable biomaterials production; expansion of its digital dentistry portfolio with the launch of the Straumann Dynamic Abutment Scanner in 2025; and a major funding commitment through a CHF 500 million convertible bond issuance in late 2024 to support growth initiatives.